The Quantum Group Announces Engagement of RedChip Companies for Investor Relations Programs
March 26 2009 - 8:02AM
PR Newswire (US)
WELLINGTON, Fla., March 26 /PRNewswire-FirstCall/ -- The Quantum
Group, Inc. (NYSE Amex: QGP) (http://www.quantummd.com/) announced
that it has hired RedChip Companies Inc. to enhance its investor
relations outreach efforts. "We selected RedChip based on their
long-history of success in broadening visibility for emerging
growth companies as well as for their expertise in market
positioning and their comprehensive platform of media services,"
said Noel J. Guillama, Chief Executive Officer of The Quantum
Group. "We're confident that RedChip will help us introduce our
story to an expanded audience and in turn foster solid and lasting
relationships with new stakeholders. We look forward to working
with their dedicated team." "We are very pleased with the
opportunity to represent The Quantum Group," said Dave Gentry,
President of RedChip Companies. He added: "With healthcare costs on
the rise and the trend toward electronic medical records, I believe
that Quantum's one-stop approach to provide technology solutions
and services to the $2.4 trillion U.S. healthcare industry is
positioning them for dramatic growth, as shown by their performance
over the last 24 months. Their web-based, healthcare technology
system that allows physicians, patients and providers communicate
in real-time addresses a huge market need at the right time. We
look forward to leveraging a comprehensive investor relations
program and introducing The Quantum Group to RedChip's investor
network." RedChip joins PR Financial Marketing in investor
relations activities for The Quantum Group, Inc. About The Quantum
Group, Inc. The Quantum Group is an innovation-driven Healthcare
Services Organization (HSO) that provides business process
solutions, service chain management, strategic consulting and
leading-edge technology to the healthcare industry. Quantum has
developed and deployed PWeR(TM), a cutting-edge, patent-pending
healthcare technology platform that has been designed to bridge the
gaps of communication and exchange of patient information
throughout the healthcare industry. PWeR can integrate all of the
functions a physician/provider, hospital, clinic and related
professionals utilize in one patient-centric, web-based platform
and falls well within the economic incentives offered by the new
$19 billion Stimulus Package for healthcare information technology.
We believe we are positioned to be a catalyst for change as we take
aim at the $700 billion inefficiency gap in the United States
healthcare industry. Certain statements contained in this news
release, which are not based on historical facts, are
forward-looking statements as the term is defined in the Private
Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the
respective company's Securities and Exchange Commission 10-KSB,
10-QSB, S-8, SB-2, S-1 and 8-K filings (and amendments thereto)
that may cause actual results to materially differ from
projections. Forward-looking statements can be identified by the
use of words such as "expects," "plans," "will," "may,"
"anticipates," "believes," "should," "intends," "estimates" "could"
and other words of similar meaning. These statements are subject to
risks and uncertainties that cannot be predicted or quantified and,
consequently, actual results may differ materially from those
expressed or implied by these forward-looking statements. Such risk
factors include, without limitation, the ability of the Company to
properly execute its business model, to raise substantial and
immediate additional capital to implement its business model, to
continue revenue growth trend in fiscal year 2009, to control
patient medical cost relative to income received, to attract and
retain executive, management and operational personnel, to continue
growing its patient base, to negotiate favorable current debt and
future capital raises, to negotiate favorable agreements with a
diversified provider base and to continue to supply the services
needed by its HMO clients as well as physician clients. We have
further risk in the deployment of our technology platform, the
utilization by our clients, technical and software setbacks, cost
of development, as well as the capital to deploy it. We are subject
further to interruptions of service. Company does not undertake any
obligation to publicly update any forward-looking statements. As a
result, investors should not place undue reliance on these
forward-looking statements. FOR MORE INFORMATION, PLEASE CONTACT:
RedChip Companies Dave Gentry: 407-644-4256, Ext. 104 or PR
Financial Marketing Jim Blackman: 713-256-0369 or The Quantum
Group, Inc. Danielle Amodio: 561.798.9800 DATASOURCE: The Quantum
Group, Inc. CONTACT: Dave Gentry of RedChip Companies,
+1-407-644-4256, Ext. 104, ; or Jim Blackman, PR Financial
Marketing, +1-713-256-0369, ; or Danielle Amodio of The Quantum
Group, Inc., +1-561-798-9800, Web Site: http://www.quantummd.com/
Copyright